TEVA MIDDLE EAST PHARM has a total of 15 patent applications. Its first patent ever was published in 1943. It filed its patents most often in Argentina, Austria and Australia. Its main competitors in its focus markets organic fine chemistry are NUTRICHEM CO LTD, MICROSULES ARGENTINA SA and MASTEAM BIO TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Argentina | 1 | |
#2 | Austria | 1 | |
#3 | Australia | 1 | |
#4 | Belgium | 1 | |
#5 | Canada | 1 | |
#6 | Switzerland | 1 | |
#7 | Germany | 1 | |
#8 | Denmark | 1 | |
#9 | Spain | 1 | |
#10 | France | 1 | |
#11 | United Kingdom | 1 | |
#12 | Netherlands | 1 | |
#13 | Norway | 1 | |
#14 | African Intellectual Property Organization | 1 | |
#15 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Schoenberg Shlomo | 6 |
#2 | Yellin Haim | 5 |
#3 | Yellin H | 2 |
#4 | Schoenberg S | 2 |
#5 | Haim Yellin | 1 |
#6 | Jellin Haim | 1 |
#7 | Shlomo Schoenberg | 1 |
Publication | Filing date | Title |
---|---|---|
CA1024988A | Derivatives of 4-chloro-5-sulfamoyl-anthranilic acid, their preparation and pharmaceutical compositions comprising them | |
GB569051A | Manufacture of derivatives of sulfanilamide |